Funders and supporters


CTC is an academic, not-for-profit, cooperative research organisation that collaborates with other researchers and conducts investigator-initiated trials. We publish independently of our supporters and uphold a core commitment to integrity and transparency in clinical trials research.

We would like to acknowledge and thank all our contributors for their ongoing investment in clinical trials research.

Your funding supports important advances in patient care for populations around the world.

  1. Abbott Laboratories
  2. Alphapharm
  3. AMGEN (Applied Molecular Genetics)
  4. ANZ Breast Cancer Trials Group (ANZ BCTG)
  5. ANZ Germ Cell Trials Group (now ANZUP)
  6. ANZ Melanoma Trials Group (ANZMTG)
  7. American Society of Clinical Oncology (ASCO)
  8. ASTA Medica Australasia
  9. Australia New Zealand Gynaecological Oncology Group (ANZGOG)
  10. Australian Research Council (ARC)
  11. Australasian Society of Thrombosis and Haemostasis (ASTH)
  12. Australasian Gastro-Intestinal Trials Group (AGITG)
  13. Australian Lung Cancer Trials Group (ALTG)
  14. Australian Lung Foundation (ALF)
  15. Australian Society for Medical Research (ASMR)
  16. AstraZeneca
  17. Aventis Pharma
  18. Bayer Group
  19. Beyond Blue
  20. Bionomics Ltd
  21. Boehringer Ingelheim
  22. Bristol-Myers Squibb
  23. Cancer Australia
  24. Cancer Council (NSW, Qld, SA, Vic, WA, Tas)
  25. Cancer Voices
  26. Cleveland Foundation
  27. Clinical Oncological Society of Australia (COSA)
  28. Comprehensive Cancer Centers, California
  29. Cooperative Trials Group for Neuro-Oncology (COGNO)
  30. CSL Bioplasma
  31. Colorectal Surgical Society of Australia and New Zealand (CSSANZ)
  32. Cure Cancer Australia
  33. Department of Education Science, and Training (DEST)
  34. Department of Health, UK
  35. Department of Health and Ageing
  36. Department of Innovation, Industry, Science and Research
  37. Eli Lilly
  38. European Organisation for Research and Treatment of Cancer (EORTC)
  39. Famitalia Carlo Erba
  40. Financial Markets Foundation for Children
  41. Fournier Laboratories SA
  42. Frontier Science and Technology Research Foundation
  43. GlaxoSmithKline
  44. Guident (USA)
  45. Gynecologic Oncology Group (GOG)
  46. HealthConsult
  47. Health Research Council of New Zealand (HRC)
  48. Heart Foundation
  49. Ian Potter Foundation
  50. JDRF Australia
  51. Kathleen Cunningham Foundation
  52. Mayne Pharma
  53. Medical Oncology Group of Australia (MOGA)
  54. Medical Research Council UK (MRC)
  55. Millenium Institute
  56. MSD
  57. University of Oxford
  58. National Breast and Ovarian Cancer Centre (NBOCC)(now part of Cancer Australia)
  59. National Breast Cancer Foundation (NBCF)
  60. National Cancer Institute of Canada Clinical Trials Group (NCI CCTG)
  61. National Centre for Gynaecological Cancers
  62. National Health and Medical Research Council (NHMRC)
  63. Novartis
  64. National Surgical Adjuvant Breast and Bowel Project (NSABP)
  65. NSW Cancer Institute
  66. NSW Ministry of Health
  67. Ovarian Cancer Research Foundation (OCRF)
  68. Pfizer Australia
  69. Pfizer Canada
  70. Prostate Cancer Foundation of Australia (PCFA)
  71. Queensland Health
  72. Roche
  73. Rotary International
  74. Royal Australasian College of Surgeons (RACS)
  75. Sanofi
  76. Solvay Pharmaceuticals
  77. Taiwan National University
  78. Telstra Foundation
  79. American College of Obstetricians and Gynecologists (ACOG)
  80. The George Institute
  81. The Medicines Company
  82. Therapeutic Innovation Australia (TIA)
  83. Trans-Tasman Radiation Oncology Group (TROG)
  84. UK Cochrane
  85. University of California
  86. University of Glasgow
  87. University of Queensland
  88. University of York
  89. US Department of Defence
  90. Waikato Breast Cancer Trust